Serum growth differentiation factor 15 is a novel biomarker with high predictive capability for liver cancer occurrence in patients with <scp>MASLD</scp> regardless of liver fibrosis
Shusuke Kumazaki(Osaka Gakuin University), Tetsuo Takehara(Osaka University), Goki Suda(Hokkaido University), Hidenori Toyoda(Ogaki Municipal Hospital), Yoshinobu Saito(The University of Osaka), Kazuhiro Murai(The University of Osaka), Yuki Tahata(The University of Osaka), Yutaka Sasaki(Iwate Medical University), Eiichi Morii(Osaka University of Economics), Yōichi Sasaki(Osaka Hospital), Kenji Fukumoto(The University of Osaka), Takahiro Kodama(The University of Osaka), Naruyasu Kakita(Takarazuka City Hospital), Takeshi Ebihara(The University of Osaka), Takashi Kojima(The University of Osaka), Ji Hyun Sung(The University of Osaka), Hayato Hikita(The University of Osaka), Sadatsugu Sakane(The University of Osaka), Tomohide Tatsumi(The University of Osaka), Kumiko Shirai(The University of Osaka), Kentaro K. Shimizu(University of Zurich), Hirokazu Takahashi(Saga University), Yuta Myojin
Cited by 20
Related Papers
aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis
|Journal of Hepatology|2020|346
The wheat powdery mildew genome shows the unique evolution of an obligate biotroph
|Nature Genetics|2013|252
Sequencing of the genus Arabidopsis identifies a complex history of nonbifurcating speciation and abundant trans-specific polymorphism
|Nature Genetics|2016|222